Advertisement

Prédispositions génétiques aux cancers de l’ovaire

  • I. Coupier
  • C. Delnatte
  • S. Lejeune-Dumoulin
  • P. This
  • M. Gauthier-Villars
  • D. Stoppa-Lyonnet
Part of the Abord clinique book series (ONCOLPRAT)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Trétarre B (2003) Ovaire. In Réseau français des registres de cancers, Hôpitaux de Lyon, Institut national de la santé et de la recherche médicale, Institut de veille sanitaire (eds) Evolution de l’incidence et de la mortalité par cancer en France de 1978 à 2000, p. 119–24Google Scholar
  2. 2.
    Auranen A, Pukkala E, Makinen J et al. (1996) Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer 74: 280–4PubMedGoogle Scholar
  3. 3.
    Stettner AR, Hartenbach EM, Schink JC et al. (1999) Familial ovarian germ cell cancer: report and review. Am J Med Genet 84: 43–6CrossRefPubMedGoogle Scholar
  4. 4.
    Giardiello FM, Brensinger JD, Tersmette AC et al. (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119: 1447–53CrossRefPubMedGoogle Scholar
  5. 5.
    Longy M, Toulouse C, Mage P et al. (1996) Familial cluster of ovarian small cell carcinoma: a new mendelian entity? J Med Genet 33: 333–5PubMedGoogle Scholar
  6. 6.
    Stratakis CA, Papageorgiou T, Premkumar A et al. (2000) Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy. J Clin Endocrinol Metab 85: 4359–66PubMedGoogle Scholar
  7. 7.
    Miki Y, Swensen J, Shattuck-Eidens D et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71PubMedGoogle Scholar
  8. 8.
    Wooster R, Bignell G, Lancaster J et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–92CrossRefPubMedGoogle Scholar
  9. 9.
    Ford D, Easton DF, Stratton M et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676–89CrossRefPubMedGoogle Scholar
  10. 10.
    Narod S, Ford D, Devilee P et al. (1995) Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium. Am J Hum Genet 57:957–8PubMedGoogle Scholar
  11. 11.
    Antoniou AC, Pharoah PD, McMullan G et al. (2002) A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86: 76–83CrossRefPubMedGoogle Scholar
  12. 12.
    Stratton JF, Gayther SA, Russell P et al. (1997) Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336: 1125–30CrossRefPubMedGoogle Scholar
  13. 13.
    Risch HA, McLaughlin JR, Cole DE et al. (2001) Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer. Am J Hum Genet 68: 700–10CrossRefPubMedGoogle Scholar
  14. 14.
    Aziz S, Kuperstein G, Rosen B et al. (2001) A genetic epidemiological study of carcinoma of the fallopian tube. Gynecol Oncol 80: 341–5CrossRefPubMedGoogle Scholar
  15. 15.
    Ford D, Easton DF, Bishop DT et al. (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692–5CrossRefPubMedGoogle Scholar
  16. 16.
    Antoniou A, Pharoah PD, Narod S et al. (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117–30CrossRefPubMedGoogle Scholar
  17. 17.
    Narod SA (2002) Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev 2: 113–23Google Scholar
  18. 18.
    Boyd J, Sonoda Y, Federici MG et al. (2000) Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. Jama 283: 2260–5CrossRefPubMedGoogle Scholar
  19. 19.
    Narod S, Tonin P, Lynch H et al. (1994) Histology of BRCA1-associated ovarian tumours. Lancet 343: 236CrossRefPubMedGoogle Scholar
  20. 20.
    Werness BA, Ramus SJ, DiCioccio RA et al. (2004) Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Int J Gynecol Pathol 23: 29–34PubMedGoogle Scholar
  21. 21.
    Lynch HT, Smyrk TC, Watson P et al. (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastro-enterology 104: 1535–49Google Scholar
  22. 22.
    Vasen HF, Mecklin JP, Khan PM et al. (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34: 424–5CrossRefPubMedGoogle Scholar
  23. 23.
    Vasen HF, Watson P, Mecklin JP et al. (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116: 1453–6CrossRefPubMedGoogle Scholar
  24. 24.
    Aaltonen LA, Peltomaki P, Leach FS et al. (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260: 812–6PubMedGoogle Scholar
  25. 25.
    Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260: 816–9PubMedGoogle Scholar
  26. 26.
    Papadopoulos N, Lindblom A (1997) Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 10: 89–99CrossRefPubMedGoogle Scholar
  27. 27.
    Liu B, Parsons R, Papadopoulos N et al. (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2: 169–74PubMedGoogle Scholar
  28. 28.
    Aarnio M, Mecklin JP, Aaltonen LA et al. (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64: 430–3PubMedGoogle Scholar
  29. 29.
    Aarnio M, Sankila R, Pukkala E et al. (1999) Cancer risk in mutation carriers of DNAmismatch-repair genes. Int J Cancer 81: 214–8CrossRefPubMedGoogle Scholar
  30. 30.
    Stratton JF, Thompson D, Bobrow L et al. (1999) The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study. Am J Hum Genet 65: 1725–32CrossRefPubMedGoogle Scholar
  31. 31.
    Salovaara R, Loukola A, Kristo P et al. (2000) Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18: 2193–200PubMedGoogle Scholar
  32. 32.
    Peel DJ, Ziogas A, Fox EA et al. (2000) Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 92: 1517–22CrossRefPubMedGoogle Scholar
  33. 33.
    Stettner AR, Hartenbach EM, Schink JC et al. (1999) Familial ovarian germ cell cancer: report and review. Am J Med Genet 84: 43–6CrossRefPubMedGoogle Scholar
  34. 34.
    Papageorgiou T, Stratakis CA (2002) Ovarian tumors associated with multiple endo-crine neoplasias and related syndromes (Carney complex, Peutz-Jeghers syndrome, von Hip-pel-Lindau disease, Cowden’s disease). Int J Gynecol Cancer 12: 337–47CrossRefPubMedGoogle Scholar
  35. 35.
    Olschwang S, Boisson C, Thomas G (2001) Peutz-Jeghers families unlinked to STK11/ LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J Med Genet 38: 356–60CrossRefPubMedGoogle Scholar
  36. 36.
    Dickersin GR, Kline IW, Scully RE (1982) Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases. Cancer 49: 188–97PubMedGoogle Scholar
  37. 37.
    Carney JA, Hruska LS, Beauchamp GD et al. (1986) Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc 61: 165–72Google Scholar
  38. 38.
    Kirschner LS, Carney JA, Pack SD et al. (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26: 89–92PubMedGoogle Scholar
  39. 39.
    Eisinger F, Bressac B, Castaigne D et al. (2004) Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004). Bull Cancer 91: 219–37PubMedGoogle Scholar
  40. 40.
    Olschwang S, Bonaiti C, Feingold J et al. (2004) Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colo-rectal and endometrial adenocarcinomas]. Bull Cancer 91: 303–15PubMedGoogle Scholar
  41. 41.
    Rebbeck TR (2002) Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Eur J Cancer 38Suppl 6: S15–7PubMedGoogle Scholar
  42. 42.
    Lynch HT, Watson P, Shaw TG et al. (1999) Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II: Hereditary non-polyposis colorectal carcinoma as a model. Cancer 86: 2457–63PubMedGoogle Scholar
  43. 43.
    Petricoin EF, Ardekani AM, Hitt BA et al. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572–7PubMedGoogle Scholar

Copyright information

© Springer-Verlag France 2006

Authors and Affiliations

  • I. Coupier
  • C. Delnatte
  • S. Lejeune-Dumoulin
  • P. This
  • M. Gauthier-Villars
  • D. Stoppa-Lyonnet

There are no affiliations available

Personalised recommendations